-
Signature - Title
-
Chris Martin - Head of Compliance
-
Location
-
Oxford
-
Holdings as of
-
30 Sep 2019
-
Num holdings
-
0
-
Filing time
-
08 Nov 2019, 14:04:31 UTC
-
Form type
-
13F-NT
-
Description
-
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). Top holdings included .
Woodford Patient Capital Trust Plc Q3 2019 Portfolio
Woodford Patient Capital Trust Plc didn't report any stock holdings as of Q3 2019.
Person Signing this Report on Behalf of Reporting Manager:
| Name |
Title |
City, State |
Date |
| Chris Martin |
Head of Compliance |
Oxford, United Kingdom |
08 Nov 2019 |
Explanatory Note: With respect to Autolus Therapeutics plc ("Autolus"), Woodford Patient Capital Trust Plc ("Woodford Patient") has executed an irrevocable proxy appointing Woodford Investment Management Ltd (the "Manager") as its sole and exclusive attorney and proxy to vote at any annual, special or adjourned meeting of the shareholders of Autolus or any class thereof and exercise all voting and related rights (to the fullest extent that Woodford Patient is entitled to do so) with respect to all of the shares of capital stock of Autolus (including ordinary shares represented by American Depositary Shares, each American Depositary Share representing one ordinary share of Autolus) (the "Autolus Shares") beneficially owned by it. Accordingly, Woodford Patient (as record holder of the shares) has no voting control over the Autolus Shares beneficially held by it. Please refer to the Explanatory Note on the Form 13F of the Manager for a description of the voting proxy granted by the Manager to Autolus with respect to the Autolus Shares beneficially owned by Woodford Patient.